Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human herpesvirus 8.

Paul T Martinelli1, Stephen K Tyring

  • 1Department of Dermatology, University of Texas-Houston Health Science Center, Houston, TX 79030, USA.

Dermatologic Clinics
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosomes in Dermatology.

Skin therapy letter·2026
Same author

Enhanced Home-Based Wart Treatment Protocol: Optimizing Debridement and Occlusion Therapy for Improved Outcomes.

Advances in skin & wound care·2026
Same author

Herpes Zoster Risk in the Era of Targeted Immunotherapy: JAK Inhibitors Versus Biologics.

Journal of cutaneous medicine and surgery·2026
Same author

Acquired Epidermodysplasia Verruciformis in Patients with Iatrogenic Immunosuppression.

Journal of clinical medicine·2026
Same author

A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Inflammopharmacology·2026
Same author

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis.

Cureus·2026
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Human herpesvirus 8 (HHV 8), or Kaposi's sarcoma-associated herpesvirus (KSHV), is a tumor virus linked to Kaposi's sarcoma and other cancers. Its oncogenic mechanisms and treatment options are under investigation.

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Human herpesvirus 8 (HHV 8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is a gamma-2 herpesvirus implicated in several human malignancies.
  • HHV 8 is a key factor in the development of Kaposi's sarcoma (KS) across all its clinical forms.
  • The virus is also associated with multicentric Castleman's disease and primary effusion lymphomas, particularly in immunosuppressed individuals.

Purpose of the Study:

  • To review the epidemiology, transmission, and clinical manifestations of HHV 8 infection.
  • To explore the molecular genetics and oncogenic mechanisms of HHV 8.
  • To summarize current treatment strategies for HHV 8-associated conditions.

Main Methods:

  • Literature review and synthesis of existing research on HHV 8.

Related Experiment Videos

  • Analysis of epidemiological data and transmission routes.
  • Examination of molecular studies on viral oncogenesis.

    • Main Results:

    • HHV 8 is consistently found in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphomas.
    • Immunosuppression significantly increases HHV 8 pathogenicity.
    • The viral genome contains cellular gene homologues involved in cell growth, suggesting molecular piracy in oncogenesis.

    Conclusions:

    • HHV 8 is a significant human tumor virus with diverse clinical associations.
    • Understanding HHV 8's molecular mechanisms is crucial for developing targeted therapies.
    • Further research is needed to elucidate oncogenic pathways and optimize treatment for HHV 8-related diseases.